Rigel Pharmaceuticals (RIGL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025)
Rigel Pharmaceuticals (RIGL) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
-13.32% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
17.12% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-14.18% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
24.11% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Rigel Pharmaceuticals |
553.93 Mn |
407.24 Mn |
54.21 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
-45.45% |
| Jun 30, 2025 |
-50.43% |
| Mar 31, 2025 |
-45.71% |
| Dec 31, 2024 |
-44.24% |
| Sep 30, 2024 |
-47.89% |
| Jun 30, 2024 |
-46.51% |
| Mar 31, 2024 |
-52.38% |
| Dec 31, 2023 |
-80.75% |
| Sep 30, 2023 |
-88.78% |
| Jun 30, 2023 |
-88.26% |
| Mar 31, 2023 |
-86.26% |
| Dec 31, 2022 |
-60.76% |
| Sep 30, 2022 |
-36.20% |
| Jun 30, 2022 |
-31.26% |
| Mar 31, 2022 |
-14.33% |
| Dec 31, 2021 |
-18.39% |
| Sep 30, 2021 |
5.48% |
| Jun 30, 2021 |
11.93% |
| Mar 31, 2021 |
-3.74% |
| Dec 31, 2020 |
23.95% |
